ALEMG — Laboratoires Euromedis SA Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapNeutral

Annual income statement for Laboratoires Euromedis SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	FAS	FAS	FAS	FAS	FAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	193	112	54.2	34	36.2
Cost of Revenue
Gross Profit	64.2	33.5	18.7	10.3	12.4
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	165	105	60	48	42.4
Operating Profit	28.7	6.42	-5.8	-14	-6.15
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	28.4	2.52	-5.98	13.4	-6.17
Provision for Income Taxes
Net Income After Taxes	22.9	2.31	-5.94	13.1	-6.17
Minority Interest
Net Income Before Extraordinary Items
Net Income	22.7	2.26	-5.93	13.1	-6.17
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	22.7	2.26	-5.93	13.1	-6.11
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	7.58	0.828	-1.91	6.35	-1.53
Dividends per Share